×
Seguir

Minoryx

Startup

The next generation of non-competitive pharmacological chaperones

SECTORES

WEB OFICIAL

Sobre Minoryx

At Minoryx, we are committed to finding innovative treatments for life threatening rare diseases. We are currently focused on Inborn Errors of Metabolism, a group of rare diseases of genetic origin with highly unmet medical need. Such diseases are life threatening and highly debilitating, usually with neurological manifestations and affect most severely the pediatric population. We develop a new generation of pharmacological chaperones, a small molecule drug class aimed to restore protein functionality and which offer one of the most promising approaches to the treatment of genetic diseases severely affecting the central nervous system. As a complementary approach, Minoryx is also involved on developing small molecule drugs which counteract the cellular dysfunctions originated by the corresponding protein deficiency.

Galería Minoryx 1

Images from Minoryx

Datos Minoryx

Oficinas
Fundacion Spain, April/2011
Estado Startup
Localizaciones
Total inversión 1.520.000€
Rondas inversión
  • Early/Startup 01/2015
    1.600,00 K€

Equipo Minoryx 0

Minoryx no tiene a su equipo agregado

Inversores Minoryx 3

Acceleradoras Minoryx 1

Noticias Minoryx 2

Política de Cookies Utilizamos cookies propias y de terceros para mejorar nuestros servicios y la experiencia de usuario. Si continúa navegando, consideramos que acepta su uso.

Aceptar